# FuboTV Inc.: financial statements, quarterly

FUBO · NYSE · CIK 1484769 · [Communication](/sectors/communication.md) · fiscal year ends Sep 30

Pages: [Overview](/companies/fubo.md) · [Financials](/companies/fubo/financials.md) · [Filings](/companies/fubo/filings.md) · [Insiders](/companies/fubo/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/fubo/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-28) | Q1 FY2025 (2025-03-29) | Q2 FY2025 (2025-06-28) | Q3 FY2025 (2025-09-30) | Q1 FY2025 (2025-12-31) | Q2 FY2026 (2026-03-31) | Q3 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [321](/filings/0001628280-24-044756.md) | [410 d](/filings/0001628280-25-009420.md) | [402](/filings/0001628280-25-022186.md) | [391](/filings/0001628280-25-039615.md) | [386](/filings/0001628280-25-048241.md) | [1,106](/filings/0001628280-26-005782.md) | [1,125](/filings/0001628280-26-031265.md) | [1,074](/filings/0001628280-26-053535.md) | [377](/filings/0001628280-25-048241.md) | [1,549](/filings/0001628280-26-005782.md) | [1,574](/filings/0001628280-26-031265.md) | [1,482](/filings/0001628280-26-053535.md) |
| Cost of revenue | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Gross profit | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Research and development | $m | [17.5](/filings/0001628280-24-044756.md) | [14.2 d](/filings/0001628280-25-009420.md) | [20.0](/filings/0001628280-25-022186.md) | [19.3](/filings/0001628280-25-039615.md) | [21.2](/filings/0001628280-25-048241.md) | [0.0](/filings/0001628280-26-005782.md) | [0.0](/filings/0001628280-26-031265.md) | [0.0](/filings/0001628280-26-053535.md) | [19.5](/filings/0001628280-25-048241.md) | [13.6](/filings/0001628280-26-005782.md) | [20.8](/filings/0001628280-26-031265.md) | [20.9](/filings/0001628280-26-053535.md) |
| Operating income | $m | [(83.3)](/filings/0001628280-24-044756.md) | [(72.1) d](/filings/0001628280-25-009420.md) | [(63.3)](/filings/0001628280-25-022186.md) | [(35.7)](/filings/0001628280-25-039615.md) | [(58.6)](/filings/0001628280-25-048241.md) | [(38.6)](/filings/0001628280-26-005782.md) | [(40.9)](/filings/0001628280-26-031265.md) | [(38.0)](/filings/0001628280-26-053535.md) | [(20.2)](/filings/0001628280-25-048241.md) | [(20.3)](/filings/0001628280-26-005782.md) | [(9.1)](/filings/0001628280-26-031265.md) | [(26.6)](/filings/0001628280-26-053535.md) |
| Interest expense | $m | [3.4](/filings/0001628280-24-044756.md) | [3.5 d](/filings/0001628280-25-009420.md) | [5.3](/filings/0001628280-24-020310.md) | [5.6](/filings/0001628280-25-039615.md) | [5.3](/filings/0001628280-25-048241.md) | [0.0](/filings/0001628280-26-005782.md) | [0.0](/filings/0001628280-26-031265.md) | [0.0](/filings/0001628280-26-053535.md) | [4.7](/filings/0001628280-25-048241.md) | [1.4](/filings/0001628280-26-005782.md) | [2.8](/filings/0001628280-26-031265.md) | [3.0](/filings/0001628280-26-053535.md) |
| Income tax | $m | [(0.2)](/filings/0001628280-24-044756.md) | [(0.4) d](/filings/0001628280-25-009420.md) | [0.1](/filings/0001628280-25-022186.md) | [0.1](/filings/0001628280-25-039615.md) | [0.2](/filings/0001628280-25-048241.md) | [0.0](/filings/0001628280-26-005782.md) | [0.0](/filings/0001628280-26-031265.md) | [0.0](/filings/0001628280-26-053535.md) | [(3.2)](/filings/0001628280-25-048241.md) | [0.4](/filings/0001628280-26-005782.md) | [0.3](/filings/0001628280-26-031265.md) | [0.7](/filings/0001628280-26-053535.md) |
| Net income | $m | [(83.8)](/filings/0001628280-24-044756.md) | [(70.1) d](/filings/0001628280-25-009420.md) | [(56.0)](/filings/0001628280-25-048241.md) | [(25.3)](/filings/0001628280-25-048241.md) | [(52.4)](/filings/0001628280-25-048241.md) | [(38.6)](/filings/0001628280-26-053535.md) | [(40.9)](/filings/0001628280-26-053535.md) | [(38.0)](/filings/0001628280-26-053535.md) | [(18.9)](/filings/0001628280-25-048241.md) | [(6.0)](/filings/0001628280-26-053535.md) | [(2.1)](/filings/0001628280-26-053535.md) | [(8.2)](/filings/0001628280-26-053535.md) |
| Diluted EPS | $ per share | [(0.29)](/filings/0001628280-24-044756.md) | not reported | [(0.19)](/filings/0001628280-25-022186.md) | [(0.08)](/filings/0001628280-25-039615.md) | [(0.16)](/filings/0001628280-25-048241.md) | not reported | [0.00](/filings/0001628280-26-031265.md) | [0.00](/filings/0001628280-26-053535.md) | [(0.06)](/filings/0001628280-25-048241.md) | [(0.02)](/filings/0001628280-26-005782.md) | [(0.07)](/filings/0001628280-26-031265.md) | [(0.25)](/filings/0001628280-26-053535.md) |
| Basic EPS | $ per share | [(0.29)](/filings/0001628280-24-044756.md) | not reported | [(0.19)](/filings/0001628280-25-022186.md) | [(0.08)](/filings/0001628280-25-039615.md) | [(0.16)](/filings/0001628280-25-048241.md) | not reported | [0.00](/filings/0001628280-26-031265.md) | [0.00](/filings/0001628280-26-053535.md) | [(0.06)](/filings/0001628280-25-048241.md) | [(0.02)](/filings/0001628280-26-005782.md) | [(0.07)](/filings/0001628280-26-031265.md) | [(0.25)](/filings/0001628280-26-053535.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: not reported
- Gross profit: not reported
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpenseNonoperating, us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-27) | Q1 FY2025 (2025-12-31) | Q2 FY2026 (2026-03-31) | Q3 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [260](/filings/0001628280-23-036731.md) | [245](/filings/0001628280-25-009420.md) | [169](/filings/0001628280-24-020310.md) | [155](/filings/0001628280-24-034986.md) | [146](/filings/0001628280-24-044756.md) | [161](/filings/0001628280-25-048241.md) | [322](/filings/0001628280-25-022186.md) | [284](/filings/0001628280-25-039615.md) | [0.0](/filings/0001628280-26-053535.md) | [452](/filings/0001628280-26-005782.md) | [238](/filings/0001628280-26-031265.md) | [230](/filings/0001628280-26-053535.md) |
| Current assets | $m | [381](/filings/0001628280-23-036731.md) | [387](/filings/0001628280-25-009420.md) | [308](/filings/0001628280-24-020310.md) | [281](/filings/0001628280-24-034986.md) | [279](/filings/0001628280-24-044756.md) | [274](/filings/0001628280-25-048241.md) | [414](/filings/0001628280-25-022186.md) | [387](/filings/0001628280-25-039615.md) | [6.7](/filings/0001628280-26-053535.md) | [983](/filings/0001628280-26-005782.md) | [903](/filings/0001628280-26-031265.md) | [892](/filings/0001628280-26-053535.md) |
| Total assets | $m | [1,220](/filings/0001628280-23-036731.md) | [1,233](/filings/0001628280-25-009420.md) | [1,144](/filings/0001628280-24-020310.md) | [1,109](/filings/0001628280-24-034986.md) | [1,102](/filings/0001628280-24-044756.md) | [1,077](/filings/0001628280-25-048241.md) | [1,216](/filings/0001628280-25-022186.md) | [1,192](/filings/0001628280-25-039615.md) | [1,303](/filings/0001628280-26-053535.md) | [4,095](/filings/0001628280-26-005782.md) | [3,981](/filings/0001628280-26-031265.md) | [3,937](/filings/0001628280-26-053535.md) |
| Current liabilities | $m | [451](/filings/0001628280-23-036731.md) | [517](/filings/0001628280-25-009420.md) | [490](/filings/0001628280-24-020310.md) | [465](/filings/0001628280-24-034986.md) | [512](/filings/0001628280-24-044756.md) | [515](/filings/0001628280-25-048241.md) | [588](/filings/0001628280-25-022186.md) | [559](/filings/0001628280-25-039615.md) | [387](/filings/0001628280-26-053535.md) | [1,164](/filings/0001628280-26-005782.md) | [908](/filings/0001628280-26-031265.md) | [888](/filings/0001628280-26-053535.md) |
| Total liabilities | $m | [887](/filings/0001628280-23-036731.md) | [949](/filings/0001628280-25-009420.md) | [908](/filings/0001628280-24-020310.md) | [855](/filings/0001628280-24-034986.md) | [880](/filings/0001628280-24-044756.md) | [897](/filings/0001628280-25-048241.md) | [827](/filings/0001628280-25-022186.md) | [792](/filings/0001628280-25-039615.md) | [387](/filings/0001628280-26-053535.md) | [1,444](/filings/0001628280-26-005782.md) | [1,326](/filings/0001628280-26-031265.md) | [1,298](/filings/0001628280-26-053535.md) |
| Long-term debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Current portion of debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Short-term borrowings | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [333](/filings/0001628280-24-044756.md) | [284](/filings/0001628280-25-048241.md) | [236](/filings/0001628280-25-048241.md) | [254](/filings/0001628280-25-048241.md) | [905](/filings/0001628280-26-053535.md) | [909](/filings/0001628280-26-053535.md) | [916](/filings/0001628280-26-053535.md) | [915](/filings/0001628280-26-053535.md) | [915](/filings/0001628280-26-053535.md) | [275](/filings/0001628280-26-053535.md) | [812](/filings/0001628280-26-053535.md) | [813](/filings/0001628280-26-053535.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: not reported
- Current portion of debt: not reported
- Short-term borrowings: not reported
- Shareholders' equity: us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-28) | Q1 FY2025 (2025-03-31) | Q3 FY2025 (2025-06-28) | Q3 FY2025 (2025-09-30) | Q1 FY2025 (2025-12-31) | Q2 FY2026 (2026-03-31) | Q3 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [(26.3) d](/filings/0001628280-24-044756.md) | [(2.1) d](/filings/0001628280-25-009420.md) | [(67.3)](/filings/0001628280-25-022186.md) | [(32.3) d](/filings/0001628280-25-039615.md) | [0.2 d](/filings/0001628280-25-048241.md) | [(42.6)](/filings/0001628280-26-005782.md) | [161](/filings/0001628280-25-022186.md) | [(37.7) d](/filings/0001628280-26-053535.md) | [(6.5) d](/filings/0001628280-25-048241.md) | [(200)](/filings/0001628280-26-005782.md) | [(212) d](/filings/0001628280-26-031265.md) | [(4.7) d](/filings/0001628280-26-053535.md) |
| Capital expenditure | $m | [0.1 d](/filings/0001628280-24-044756.md) | [0.7 d](/filings/0001628280-25-009420.md) | [0.1](/filings/0001628280-25-022186.md) | [0.2 d](/filings/0001628280-25-039615.md) | [1.6 d](/filings/0001628280-25-048241.md) | [0.0](/filings/0001628280-26-005782.md) | [0.3](/filings/0001628280-25-022186.md) | [0.0 d](/filings/0001628280-26-053535.md) | [0.0 d](/filings/0001628280-25-048241.md) | [0.5](/filings/0001628280-26-005782.md) | [0.1 d](/filings/0001628280-26-031265.md) | [0.5 d](/filings/0001628280-26-053535.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment

## Shares

| Line item | Unit | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-29) | Q2 FY2025 (2025-06-28) | Q3 FY2025 (2025-09-30) | Q1 FY2025 (2025-12-31) | Q2 FY2026 (2026-03-31) | Q3 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [225](/filings/0001628280-24-020310.md) | [292](/filings/0001628280-24-034986.md) | [293](/filings/0001628280-24-044756.md) | [299](/filings/0001628280-25-022186.md) | [311](/filings/0001628280-25-039615.md) | [332](/filings/0001628280-25-048241.md) | [0.0](/filings/0001628280-26-031265.md) | [0.0](/filings/0001628280-26-053535.md) | [343](/filings/0001628280-25-048241.md) | [349](/filings/0001628280-26-005782.md) | [30.7](/filings/0001628280-26-031265.md) | [32.8](/filings/0001628280-26-053535.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 342,433,118 at 2025-07-31, from the cover of the [10-Q filed 2025-08-11](/filings/0001628280-25-039615.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:41 ET. No prices; not investment advice.